| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/15/2007 | US20070059374 Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces |
| 03/15/2007 | US20070059373 Method of Drug Formulation Based on Increasing the affinity of Crystalline Microparticle Surfaces for Active Agents |
| 03/15/2007 | US20070059372 Use of autologous sediment from fluid aspirates as vehicles for drug delivery |
| 03/15/2007 | US20070059371 Nanoparticulate ebastine formulations |
| 03/15/2007 | US20070059370 Method and apparatus for fabricating nanoparticles |
| 03/15/2007 | US20070059369 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 03/15/2007 | US20070059368 Modified release formulations of anti-irritability drugs |
| 03/15/2007 | US20070059367 Drug Delivery System and Associated Methods |
| 03/15/2007 | US20070059366 1-(8-{4-[3-(5-Fluoro-1H-indol-3-yl)-propyl]-piperazin-1-yl}-2-methyl-4H-benzo[1,4]oxazin-3-one (SLV 314); coated tablet comprising compressed comprises hypromellose, microcrystalline cellulose, and lubricant; G protein coupled receptor inhibitors; solubility, stability and ease of formulation |
| 03/15/2007 | US20070059365 Novel formulation of ropinirole |
| 03/15/2007 | US20070059364 Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity |
| 03/15/2007 | US20070059363 Continuously introducing the mixed fluids into a dryer from the two or more different fluids for preparation of sustained release microspheres containing a biodegradable polymer, a drug, an additive and a solvent with different types of contents or both of the components, by controlling the mixing ratios |
| 03/15/2007 | US20070059362 Effervescent rehydrating beverage tablet/granules |
| 03/15/2007 | US20070059361 Fast-disintegrating epinephrine tablets for buccal or sublingual administration |
| 03/15/2007 | US20070059360 Water-dispersible anti-retroviral pharmaceutical compositions |
| 03/15/2007 | US20070059359 Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof |
| 03/15/2007 | US20070059358 Matrix adjuvants and the drop pills prepared with them |
| 03/15/2007 | US20070059357 Adiponectin production enhancer |
| 03/15/2007 | US20070059355 Liquid filled delivery system |
| 03/15/2007 | US20070059354 Sustained release dosage forms of oxcarbazepine |
| 03/15/2007 | US20070059353 Polyarginine-modified liposome having nuclear entry ability |
| 03/15/2007 | US20070059352 Therapeutic liposomes |
| 03/15/2007 | US20070059351 Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods |
| 03/15/2007 | US20070059349 Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 03/15/2007 | US20070059347 Antibacterial fiber assembly and production method and uses thereof |
| 03/15/2007 | US20070059346 Film comprising therapeutic agents |
| 03/15/2007 | US20070059345 Method for tissue growth |
| 03/15/2007 | US20070059341 Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy |
| 03/15/2007 | US20070059338 Compositions and techniques for localized therapy |
| 03/15/2007 | US20070059318 Lipid nano particulates containing antigens as cancer vaccines |
| 03/15/2007 | US20070059298 Method for administering a vaginal care composition |
| 03/15/2007 | US20070059295 Compositions and Methods for the Prevention and Removal of Biofilms on Inert and Biological Surfaces |
| 03/15/2007 | US20070059289 Methods of improving cardiac function and attenuating and/or preventing cardiac remodeling with Hsp20 |
| 03/15/2007 | US20070059285 Human serum albumin-free stabilized interferon liquid formulations |
| 03/15/2007 | US20070059271 polyethylene glycol/poly( beta -benzyl-L-aspartate)-ac block copolymer; useful as carrier for in vivo delivery of active substances such as DNA; enables provision of PIC micelles having higher gene transfer effectivity |
| 03/15/2007 | US20070059261 Antimycotic nail polish formulations comprising substituted 2-aminothiazoles as an active substance |
| 03/15/2007 | US20070059255 Preventing or treating viral, bacterial, fungal and yeast infections and cancer by administering an aqueous mixture including a peroxygen compound (peracid and peroxide) and a transition metal or alloy; may also include an alcohol |
| 03/15/2007 | US20070059254 Compositions for delivering 5-ht agonists across the oral mucosa and methods of use thereof |
| 03/15/2007 | US20070059253 drug delivery; skin disorders; supplying corticosteroid and fungicides |
| 03/15/2007 | US20070059252 follicle stimulating hormone (FSH) and luteinising hormone (LH); surfactant such as polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monopalmitate, and polyoxyethylene sorbitan monooleate, and stabilizer and tonicity agent such as monosaccharides, disaccharides and sugar alcohols |
| 03/15/2007 | US20070059248 Oxygen delivery agents and uses for the same |
| 03/15/2007 | US20070056511 Pharmaceutical dispensing apparatus and method |
| 03/15/2007 | DE102005043172A1 Verfahren zur Herstellung von Weichkapselhüllen auf Basis von Polyvinylalkohol-Polyethylenglykol-Pfropfcopolymeren A method for producing soft capsule shells based on polyvinyl alcohol-polyethylene glycol graft copolymer |
| 03/15/2007 | DE102005042768A1 Magnetfeld-gesteuerter Wirkstofftransfer für die Aerosoltherapie Magnetic field controlled drug transfer for aerosol therapy |
| 03/15/2007 | CA2621800A1 Fine particles of poorly soluble drug having enteric base material adsorbed on the surface thereof |
| 03/15/2007 | CA2621545A1 Ramipril formulation |
| 03/15/2007 | CA2621263A1 Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| 03/15/2007 | CA2621055A1 Sustained-release microsphere containing short chain deoxyribonucleic acid or short chain ribonucleic acid and method of producing the same |
| 03/15/2007 | CA2621015A1 New use for a composition comprising chloroprocaine hcl, a new composition comprising chloroprocaine hcl and a method for its manufacture |
| 03/15/2007 | CA2620491A1 Pharmaceutical dosage forms and compositions comprising lecoztan |
| 03/15/2007 | CA2620164A1 Topical formulations containing o-desmethyl venlafaxine (odv) or its salts |
| 03/15/2007 | CA2620160A1 Transdermal drug delivery devices containing o-desmethyl venlafaxine (odv) or its salts |
| 03/15/2007 | CA2608444A1 Formulations containing pantoprazole free acid and its salts |
| 03/15/2007 | CA2603817A1 Compositions containing micronized tanaproget prepared by wet granulation |
| 03/14/2007 | EP1762849A1 Method for demonstrating efficacy of a topically applied active ingredient |
| 03/14/2007 | EP1762249A2 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 03/14/2007 | EP1762235A1 Orally adminstered composition for preventing neonatal hemorrhages, in a tardy form, caused by a K-vitamin deficiency |
| 03/14/2007 | EP1762232A1 Liquid filled delivery system, preferably an HPMC capsule filled with glycerol |
| 03/14/2007 | EP1762231A1 Sustained release magnesium microtablets |
| 03/14/2007 | EP1762230A1 Filmtablet or granulate comprising a pyridylpyrimidine |
| 03/14/2007 | EP1762229A2 Sprayable personal lubricant |
| 03/14/2007 | EP1762228A2 Sprayable personal lubricant |
| 03/14/2007 | EP1762227A2 Compositions, uses and kits for treating allergic dermatitis of skin |
| 03/14/2007 | EP1762226A2 Topical formulations in the form of gels containing acyclovir and lidocaine as active ingredients |
| 03/14/2007 | EP1761283A2 Biodegradable drug-polymer delivery system |
| 03/14/2007 | EP1761265A2 A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device |
| 03/14/2007 | EP1761261A1 Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| 03/14/2007 | EP1761260A1 Compression coated tablet comprising sumatriptan |
| 03/14/2007 | EP1761252A1 Matrix-controlled transdermal therapeutic system based on an adhesive for administering norelgestromin or the combination thereof with an estrogen |
| 03/14/2007 | EP1761251A1 Lipid nanoparticles as vehicles for nucleic acids, process for their preparation and use |
| 03/14/2007 | EP1761250A1 Oral delivery system |
| 03/14/2007 | EP1761249A1 Injectable microspheres from unsaturated functionalized polyhydric alcohol esters |
| 03/14/2007 | EP1761248A1 Carbohydrate-derivatized liposomes for targeting cellular carbohydrate recognition domains of ctl/ctld lectins, and intracellular delivery of therapeutically active compounds |
| 03/14/2007 | EP1761247A1 Injectable pharmaceutical suspension comprising posaconazole |
| 03/14/2007 | EP1761246A1 Aqueous dispersions of low-water-solubility or water-insoluble active substances and dry powders produced therefrom |
| 03/14/2007 | EP1761245A2 Natural extract containing xanthohumol, and method for the production thereof and products produced therefrom |
| 03/14/2007 | EP1761244A1 Isocyanate-based compositions and their use |
| 03/14/2007 | EP1761243A1 Tobacco alkaloid releasing chewing gum |
| 03/14/2007 | EP1761242A2 Film-shaped estriol-containing medicament for oral administration |
| 03/14/2007 | EP1761204A2 Implantable device for treating disease states and methods of using same |
| 03/14/2007 | EP1694311A4 Chewable soft capsules containing ungelatinized starch |
| 03/14/2007 | EP1658055B1 Form of administration secured against misuse |
| 03/14/2007 | EP1526839B1 Oral pharmaceutical forms of liquid drugs having improved bioavailability |
| 03/14/2007 | EP1502595B1 An injection made from ixeris sonchifolia for treatment of cardio-cerebral vascular disease and fundus diseases and method of producing thereof |
| 03/14/2007 | EP1467706B1 Dermal application system for aminolevulinic acid-derivatives |
| 03/14/2007 | EP1448235B1 Oral controlled release pharmaceutical compositions of 5,8,14-triazatetracyclo 10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene |
| 03/14/2007 | EP1427394B1 Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities |
| 03/14/2007 | EP1399152B1 Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid mono-ester |
| 03/14/2007 | EP1385502B1 Medicament comprising an anhydrous formulation of xanthogenate |
| 03/14/2007 | EP1372667A4 Compositions for delivering bisphosphonates |
| 03/14/2007 | EP1347764B1 Gel composition based on alcohol for the treatment of hypogonadism through transscrotal application |
| 03/14/2007 | EP1345683B1 Encapsulation of emulsions |
| 03/14/2007 | EP1337238B1 Generation of therapeutic microfoam |
| 03/14/2007 | EP1259262B1 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 03/14/2007 | EP1254180B1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody |
| 03/14/2007 | EP1216031B1 Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 03/14/2007 | EP1196197B1 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene |
| 03/14/2007 | EP1171101B1 Method for producing a water-insoluble amorphous controlled release matrix |
| 03/14/2007 | EP1041978B1 Methods of inactivating bacteria including bacterial spores |
| 03/14/2007 | EP1011637B1 Modulation of drug loading in multivesicular liposomes |